RecruitingNot ApplicableNCT06360627
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Sponsor
University of Zurich
Enrollment
100 participants
Start Date
Feb 20, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- CT SCAN for pulmonary nodule detection/follow up
- CT SCAN for pneumonia detection/follow up
Exclusion Criteria2
- under 18
- BMI over 30
Interventions
RADIATIONComputed Tomography
Computed Tomography CHEST
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06360627
Related Trials
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Virtual Agent Feasibility in Oncology Patients (NTT Data)
NCT066820131 location
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667100 locations
Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block
NCT066185991 location
Rhomboid Intercostal Block vs Erector Spinae Block
NCT070406181 location